What if future treatments for lymphatic malformations could target the disease more precisely while reducing side effects?
In this seminar, surgeon-scientist Dr. Graham Strub shares his latest research on next-generation therapies for lymphatic malformations (LMs). His team is studying microRNAs—tiny molecules that help regulate how cells grow—and how they may be used to slow the abnormal growth of lymphatic malformations.
Dr. Strub also discusses exciting advances in nanoparticle technology, which could one day deliver these therapies directly to lymphatic malformations instead of affecting the entire body. While this research is still in the preclinical stage, it represents an important step toward more targeted, personalized treatments.
In this presentation you'll learn:
- What lymphatic malformations are and why they are difficult to treat
- How PIK3CA mutations contribute to disease
- What microRNAs are and why they matter
- How multi-omics research is uncovering new treatment targets
- The potential of nanoparticle-based therapies
- What these discoveries could mean for future patient care
